louisiana glp-1 intestinal paralysis class action The RA Legal Timeline: How Serious Side Effects Led to Multidistrict Litigation louisiana semaglutide gastroparesis lawsuit glp-1
Description
What You Should Not Expect Rapid results in the first weeks
A central issue in GLP-1 litigation is that the same mechanism that helps regulate appetite and glucose levels may also interfere with normal gastrointestinal motility
About four in ten adults ages 50 to 64 and 65 and older say they have heard a lot about GLP-1 drugs, compared to about one-third of adults ages 30-49 (32%) and one in six adults ages 18-29 (17%)
Plaintiffs already allege that Novo Nordisk failed to warn about risks such as gastroparesis and vision loss
